Clinical trial
Cohort Study for Patients Using Fuzeon (Enfuvirtide)
NCT00216359 · Institute for Interdisciplinary Infectiology, Other · Unknown status
Key facts
| NCT number | NCT00216359 |
|---|---|
| Title | Cohort Study for Patients Using Fuzeon (Enfuvirtide) |
| Official title | The Radata-Fuzeon Cohort - An Observational Cohort-Study in HIV-Infected Patients Using Fuzeon (Enfuvirtide) as Part of Their Antiretroviral Combination Therapy |
| Lead sponsor | Institute for Interdisciplinary Infectiology, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | HIV Infections, Antiretroviral Treatment |
| Intervention type | Drug, Procedure |
| Interventions | Fuzeon (Enfuvirtide), Laboratory diagnostic (CD4-cells), Laboratory diagnostics (HIV-1 viral load), antiretroviral co-medication beside Fuzeon |
| Enrollment | 200 |
| Start date | May 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 25, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: